These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1188778)

  • 1. Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
    David JL; Herion FP
    Thromb Diath Haemorrh; 1975 Sep; 34(1):341. PubMed ID: 1188778
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin neutralization of antiplatelet effect of aspirin and dipyridamole.
    Mohammad SF; Kim SW; Olsen DB
    ASAIO Trans; 1988; 34(3):322-7. PubMed ID: 2848561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early platelet-collagen interactions in whole blood and their modifications by aspirin and dipyridamole evaluated by a new method (BASIC wave).
    Pérez-Requejo JL; Aznar J; Santos MT; Vallés J
    Thromb Haemost; 1985 Dec; 54(4):799-803. PubMed ID: 4089814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced platelet surface alterations. A possible mechanism for impaired aggregation.
    Djaldetti M; Bessler H; Fishman P
    Haematologica; 1978 Oct; 63(5):531-47. PubMed ID: 107072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet aggregate formation in peripheral blood anti-coagulated with sodium heparin is facilitated by mixing].
    Shimasaki AK; Ozaki Y
    Rinsho Ketsueki; 1997 Apr; 38(4):323-30. PubMed ID: 9146062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of thrombus structure for the antithrombotic effectiveness of thrombocyte aggregation inhibiting substances and anticoagulants].
    Zimmermann R; Lange D; Zeltsch C; Barth P; Mörl H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1173-4. PubMed ID: 347772
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition by heparin of platelet accumulation in vivo.
    Barrett PA; Butler KD; Morley J; Page CP; Paul W; White AM
    Thromb Haemost; 1984 Jul; 51(3):366-70. PubMed ID: 6495256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood platelet function in patients treated with verapamil. Comparison with dipyridamole and acetyl salicylic acid].
    Martínez-Brotons F; Portis T; Simón R; Pérez-Ayuso MJ; Kian C; Reynaldo C; Gausí C
    Med Clin (Barc); 1987 Jun; 89(3):104-7. PubMed ID: 3626647
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF; May JA; Heptinstall S
    Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aspirin resistance detection and validation.
    Hillman RS
    J Am Coll Cardiol; 2006 Jun; 47(12):2565; author reply 2566. PubMed ID: 16781390
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of platelet-suppressive agents.
    Wautier JL; Caen JP
    Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.